These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 22336948)
41. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome. Zingkou E; Pampalakis G; Sotiropoulou G Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165831. PubMed ID: 32442469 [TBL] [Abstract][Full Text] [Related]
42. Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. Pazgier M; Ericksen B; Ling M; Toth E; Shi J; Li X; Galliher-Beckley A; Lan L; Zou G; Zhan C; Yuan W; Pozharski E; Lu W Biochemistry; 2013 Mar; 52(9):1547-58. PubMed ID: 23406372 [TBL] [Abstract][Full Text] [Related]
43. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients. Komatsu N; Saijoh K; Kuk C; Liu AC; Khan S; Shirasaki F; Takehara K; Diamandis EP Exp Dermatol; 2007 Jun; 16(6):513-9. PubMed ID: 17518992 [TBL] [Abstract][Full Text] [Related]
44. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of outer membrane proteases of the omptin family by aprotinin. Brannon JR; Burk DL; Leclerc JM; Thomassin JL; Portt A; Berghuis AM; Gruenheid S; Le Moual H Infect Immun; 2015 Jun; 83(6):2300-11. PubMed ID: 25824836 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6. Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1). Jendrny C; Beck-Sickinger AG Chembiochem; 2016 Apr; 17(8):719-26. PubMed ID: 26574674 [TBL] [Abstract][Full Text] [Related]
49. Novel inhibitory activity for serine protease inhibitor Kazal type-3 (Spink3) on human recombinant kallikreins. Assis DM; Zalazar L; Juliano MA; De Castro R; Cesari A Protein Pept Lett; 2013 Oct; 20(10):1098-107. PubMed ID: 23590280 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Cole AM; Shi J; Ceccarelli A; Kim YH; Park A; Ganz T Blood; 2001 Jan; 97(1):297-304. PubMed ID: 11133774 [TBL] [Abstract][Full Text] [Related]
51. Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Ohler A; Debela M; Wagner S; Magdolen V; Becker-Pauly C Biol Chem; 2010 Apr; 391(4):455-60. PubMed ID: 20128684 [TBL] [Abstract][Full Text] [Related]
52. Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor. López-García B; Lee PH; Gallo RL J Antimicrob Chemother; 2006 May; 57(5):877-82. PubMed ID: 16556635 [TBL] [Abstract][Full Text] [Related]
53. The use of doxycycline as a protectant against sulphur mustard in HaCaT cells. Lindsay CD; Gentilhomme E; Mathieu JD J Appl Toxicol; 2008 Jul; 28(5):665-73. PubMed ID: 18069744 [TBL] [Abstract][Full Text] [Related]
54. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. Curci JA; Mao D; Bohner DG; Allen BT; Rubin BG; Reilly JM; Sicard GA; Thompson RW J Vasc Surg; 2000 Feb; 31(2):325-42. PubMed ID: 10664501 [TBL] [Abstract][Full Text] [Related]